Bottom line
What is PSIJX's expense ratio?
PSIJX's expense ratio is 1.14%, or about $114 a year on every $10,000 invested. That is more expensive than 64% of small-cap funds we track (median 0.99%). Its expense ratio includes a 0.15% 12b-1 marketing fee.
Updated Feb 27, 2026
PSIJX fee table
| Net expense ratio | 1.14% |
|---|---|
| Gross expense ratio | 1.16% |
| Management fee | 0.85% |
| 12b-1 (distribution) fee | 0.15% |
| Other expenses | 0.13% |
| Acquired fund fees | 0.03% |
| Fee waiver / reimbursement | -0.02% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Feb 27, 2026
What PSIJX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PSIJX | $216 | $366 | $636 | $1,407 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.14% expense ratio costs roughly $62,400 in lost growth, versus about $54,900 for the median small-cap fund (0.99%).